UNSPSC 51431905: Exaprolol hydrochloride

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H29NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FGT82HNC7L, chemically known as 2-propanol, 1-(2-cyclohexylphenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (+-)- but more generally known as exaprolol hydrochloride, which bears US NIH Compound Identifier 65484. Most nations, for tariff and trade purposes, schedule exaprolol hydrochloride under HS 29221980 and SITC 51461.

As of Q4 2014, EXAPROLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Exaprolol hydrochloride bears US NLM identifiers UMLS ID C0952592 and NCI Concept Code C65610. SMILES: CC(C)NCC(COC1CCCCC1C2CCCCC2)O.CL.

UNSPSC 51431905 Exaprolol hydrochloride is a Commodity code identifying a specific pharmaceutical active ingredient; however, state and local procurement activity under this code tag appears minimal, with recent solicitations treating advanced life support medications as aggregated line-item purchases rather than single-ingredient procurements. The City of Tampa's April 2026 sealed-bid solicitation for Advanced Life Support Medications illustrates the actual buying pattern: municipalities procure finished injectable medications for emergency medical services in mixed lots, specifying multiple agents (Labetalol, Epinephrine, Adenosine, Diltiazem) by formulation, unit count, and shelf-life requirement rather than by active pharmaceutical ingredient. Fire rescue and emergency medical service departments at the city level are the primary end-users, with purchasing offices acting as the contracting authority. Vendors must meet pharmaceutical supply-chain standards including nine-month minimum expiration dates from acceptance, ten-day delivery timelines, 365-day defect warranties, and OSHA-compliant Safety Data Sheets.

The Tampa solicitation (Bid 26-P-00188, due April 8, 2026, estimated value $40,000) represents the only recent state-local opportunity tagged to this code in the source. The solicitation carries a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount capped at $10,000 and requires WCAG 2.2 Level AA accessibility documentation alongside pharmaceutical compliance. The contract term runs one year with two optional one-year renewals plus unilateral City extension rights for three 30-day periods. Florida activity dominates the limited visible record; no other states or jurisdictions appear in the recent-opportunities block. The mismatch between the Commodity code's ingredient-level specificity and the actual procurement pattern—bundled multi-medication lots for emergency response—suggests this code may not align well with how state and local agencies structure their medication purchasing.